BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29332347)

  • 1. Genetically engineered bone marrow-derived mesenchymal stem cells co-expressing IFN-γ and IL-10 inhibit hepatocellular carcinoma by modulating MAPK pathway.
    Wang H; Wang J; Shi X; Ding Y
    J BUON; 2017; 22(6):1517-1524. PubMed ID: 29332347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway.
    Xie C; Xie DY; Lin BL; Zhang GL; Wang PP; Peng L; Gao ZL
    Br J Cancer; 2013 Sep; 109(5):1198-205. PubMed ID: 23887606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-α2b gene-modified human bone marrow mesenchymal stem cells inhibit hepatocellular carcinoma by reducing the Notch1 levels.
    Su Y; Cheng R; Zhang J; Qian J; Diao C; Ran J; Zhang H; Li L
    Life Sci; 2015 Dec; 143():18-26. PubMed ID: 26518164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.
    Mi F; Gong L
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28659496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats.
    Xu G; Guo Y; Seng Z; Cui G; Qu J
    Oncol Rep; 2015 Oct; 34(4):1915-22. PubMed ID: 26252165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
    Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
    Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma.
    Seyhoun I; Hajighasemlou S; Muhammadnejad S; Ai J; Nikbakht M; Alizadeh AA; Hosseinzadeh F; Mirmoghtadaei M; Seyhoun SM; Verdi J
    J Cell Physiol; 2019 Jun; 234(6):9495-9503. PubMed ID: 30362607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of bone marrow mesenchymal stem cells with CTLA4Ig and CD40LIg gene modification in rejection reaction after liver transplantation].
    Sun C; Zhang J; Yin DL; Li K; Wang Q; Xie YH; Li W
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):54-59. PubMed ID: 29804363
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of CCR1 gene overexpression on the migration of bone marrow - derived mesenchymal stem cells towards hepatocellular carcinoma].
    Gao Y; Huang XL; Zhang L; Deng L; Yin AH; Sun BC; Lu S
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):354-359. PubMed ID: 28763842
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of immuno-tolerance mechanism of the third-party bone marrow-derived mesenchymal stem cells in allogenic transplantation].
    Qi BD; Meng BX; Yang Y; Liu B; Li CC; Xia W; Guo SZ; Zhang C
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):207-12. PubMed ID: 21838003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation.
    Zhou X; Zhu A; Gu X; Xie G
    Cell Oncol (Dordr); 2019 Jun; 42(3):369-380. PubMed ID: 30788663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of IL-12 gene-modified bone marrow mesenchymal stem cells combined with Fuzheng Yiliu decoction in an in vivo glioma nude mouse model.
    Wu J; Xie S; Li H; Zhang Y; Yue J; Yan C; Liu K; Liu Y; Xu R; Zheng G
    J Transl Med; 2021 Apr; 19(1):143. PubMed ID: 33827606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour-bearing mice.
    Liu QW; Li JY; Zhang XC; Liu Y; Liu QY; Xiao L; Zhang WJ; Wu HY; Deng KY; Xin HB
    J Cell Mol Med; 2020 Sep; 24(18):10525-10541. PubMed ID: 32798252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
    Jung JW; Yoon SM; Kim S; Jeon YH; Yoon BH; Yang SG; Kim MK; Choe S; Kuo MM
    Oncotarget; 2016 Nov; 7(45):73754-73768. PubMed ID: 27650540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model.
    Huang Y; Gao J; Zhou Y; Wu S; Shao Y; Xue H; Shen B; Ding L; Wei Z
    Stem Cell Res Ther; 2020 Jul; 11(1):278. PubMed ID: 32650831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow mesenchymal stromal cells attenuate silica-induced pulmonary fibrosis potentially by attenuating Wnt/β-catenin signaling in rats.
    Zhang E; Yang Y; Chen S; Peng C; Lavin MF; Yeo AJ; Li C; Liu X; Guan Y; Du X; Du Z; Shao H
    Stem Cell Res Ther; 2018 Nov; 9(1):311. PubMed ID: 30428918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
    Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
    Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interleukin-17 promotes mouse hepatoma cell proliferation by antagonizing interferon-γ].
    Li J; Yan K; Yang Y; Li H; Wang Z; Xu X
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):1-5. PubMed ID: 30692059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
    Liang L; Zhao L; Wang Y; Wang Y
    Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
    Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
    Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.